Syneos Health Inc - Class A logo

SYNH

Syneos Health Inc - Class A

$67.64

Earnings Summary

Revenue
$1360.74Mn
Net Profits
$77.74Mn
Net Profit Margins
5.71%
PE Ratio
31.21

Highlights

Revenue:

Syneos Health Inc - Class A’s revenue jumped 6.09% since last year same period to $1360.74Mn in the Q2 2022. On a quarterly growth basis, Syneos Health Inc - Class A has generated 1.83% jump in its revenue since last 3-months.

Net Profits:

Syneos Health Inc - Class A’s net profit jumped 85.52% since last year same period to $77.74Mn in the Q2 2022. On a quarterly growth basis, Syneos Health Inc - Class A has generated 68.36% jump in its net profits since last 3-months.

Net Profit Margins:

Syneos Health Inc - Class A’s net profit margin jumped 74.87% since last year same period to 5.71% in the Q2 2022. On a quarterly growth basis, Syneos Health Inc - Class A has generated 65.33% jump in its net profit margins since last 3-months.

PE Ratio:

Syneos Health Inc - Class A’s price-to-earnings ratio after this Q2 2022 earnings stands at 31.21.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Syneos Health Inc - Class A post its latest quarter earnings

EPS Estimate Current Quarter
1.35
EPS Estimate Current Year
1.35

Highlights

EPS Estimate Current Quarter:

Syneos Health Inc - Class A’s earning per share (EPS) estimates for the current quarter stand at 1.35 - a 12.5% jump from last quarter’s estimates.

EPS Estimate Current Year:

Syneos Health Inc - Class A’s earning per share (EPS) estimates for the current year stand at 1.35.

Key Ratios

Key ratios of the Syneos Health Inc - Class A post its Q2 2022 earnings

Earning Per Share (EPS)
1.25
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.07
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Syneos Health Inc - Class A’s earning per share (EPS) jumped 28.87% since last year same period to 1.25 in the Q2 2022. This indicates that the Syneos Health Inc - Class A has generated 28.87% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Syneos Health Inc - Class A’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Syneos Health Inc - Class A’s return on equity (ROE) stands at 0.07.

Dividend Per Share (DPS):

Syneos Health Inc - Class A declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-29
0.95
1.01
6.32%
2022-08-02
1.2
1.25
4.17%

Company Information

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

Organisation
Syneos Health Inc - Class A
Headquarters
Morrisville, North Carolina, US
Employees
24.31K
Industry
Health Services